Sign Up Now
Watch the best videos collected by Libby's H*O*P*E* (tm).
Join 49 others following Libby's H*O*P*E* (tm)'s collection of 851 videos. It's free to sign up.
Libby's H*O*P*E* (tm)
Libby's H*O*P*E* - An on-line resource dedicated to the support of ovarian cancer survivors and their families through various on-line medical and education resources based upon the principle that "information is power." The empowerment of all ovarian cancer survivors through educational awareness allows them to persevere in their fight against ovarian cancer and proactively choose hope.
851 Videos
Member since May 1, 2008
Twitter @libbyshope
http://healthinfoispower.word...
http://twitter.com/libbyshope
Collections
Statistics
| 851 | Videos |
| Monthly Views |
Top Tags
-
RPCI Launches Landmark Immunotherapy Vaccine Trial
Roswell Park Cancer Institute has launched a phase I solid tumor clinical study of a NY-ESO-1 dendritic cell vaccine (in combination with rapamycin) designed to both eradicate cancer cells and prevent disease relapse. (24 Jan 12)Collected in Libby's H*O*P*E* Jan 25, 2012 -
Clinical Trials & Safety with Eric Singer, MD, MA
Dr. Eric Singer explains how clinical trials are reviewed to ensure the safety of the patients involved. (02 May 11).Collected in Libby's H*O*P*E* May 2, 2011 -
Avastin Phase III Trials (GOG218, ICON7, OCEANS) - WORD of HOPE Ovarian Cancer Postcast
This video addresses preliminary data from the recent Phase III Avastin clinical trials which are testing the drug in newly-diagnosed and recurrent ovarian cancer patients. It is the first episode in a podcast series entitled, "10 Exciting 2010 Ovarian Cancer Research Topics." The series is co-hosted by Nate Manahan, WORD Executive Director, and Paul Cacciatore, founder of Libby's H*O*P*E*. Visit www.wordofhopepodcast.com.Collected in Libby's H*O*P*E* Mar 25, 2011 -
ESMO 2010: The ICON7 Trial & Bevacizumab
Prof. Timothy Perren explains the results of the ICON7 trial investigating the use of bevacizumab to treat advanced ovarian cancer. This trial compared standard chemotherapy of carboplatin and paclitaxel with a treatment programme of carboplatin, paclitaxel and bevacizumab. Disease progression was found to be delayed and occurred less frequently in the bevacizumab group. Prof Perren discusses how representative the patient population was, considers the effect of residual disease status and outlines some ofCollected in Libby's H*O*P*E* Nov 4, 2010 -
Phases of a Cancer Clinical Trial, with Nicholas Petrelli, MD | Cancer.Net
Dr. Nicholas Petrelli explains how clinical cancer research is done in distinct segments, called the phases of a clinical trial. 03 Nov. 10Collected in Libby's H*O*P*E* Nov 3, 2010 -
2010 ASCO: Clinical Trials Report - Vital Options
At ASCO 2010, Vital Options produced Advocacy in Action with the support of Novartis Oncology, Lilly Oncology and Genentech. Over 17 advocates participated from all cancer types and featuring: Diane Blum (Lymphoma Research Foundation), Cara Tenenbaum (Ovarian Cancer National Alliance), Kim Thiboldeaux (Cancer Support Community), Elyse Spatz Caplan (Living Beyond Breast Cancer), Brian Tomlinson (Lymphoma Research Foundation), Harriet Patterson (National Brain Tumor Society), Tim Turnham (Melanoma Research FoCollected in Libby's H*O*P*E* Jul 28, 2010 -
Olaparib -- A Novel Drug To Treat Hereditary Breast & Ovarian Cancer
Dr Andrew Tutt, Consultant Clinical Oncologist and Director of the Breakthrough Breast Cancer Research Unit at King's College London, discussing olaparib, the first of a totally new type of cancer treatments that is showing promise for patients with inherited forms of breast and ovarian cancer. 06 Jul 10Collected in Libby's H*O*P*E* Jul 6, 2010 -
Clinical trial Design: Comparator arms
Prof David Cameron chairs a round table debate on clinical trial design and comparator arms. The discussion examines issues such as the need to fast forward drug evaluation of targeted agents, how to detect unpredictable side effects of targeted compounds and how fast can combinations be evaluated. 30 Jun 10Collected in Libby's H*O*P*E* Jun 30, 2010 -
Novartis Ovarian Cancer Drug Patupilone Fails in Phase III Trials
Ovarian cancer candidate patupilone fails in phase III trials. 04 Jun 10Collected in Libby's H*O*P*E* Jun 4, 2010 -
"WORDs of Wisdom" Dr. John Geisler - Importance of Clinical Trials
"WORDS of Wisdom" doctor Interview series. Dr. John Geisler discusses the importance of cancer patients involvement in clinical trials. For more information re WORD & gynecologic cancer, go to http://wordoncancer.org/word_website/. 04 Jun 10Collected in Libby's H*O*P*E* Jun 4, 2010 -
Participating In Cancer Clinical Trials: Part 2 - Making Your Decision
Part 2 of a National Cancer Institute Cancer clinical trials educational video created for people who are considering participation in a trial. The video explains and answers common questions about the types of clinical trials, how they are conducted, and factors to think about when deciding whether or not to participate in a trial. The video also features actual patients who share their reasons and decisions about participating in Cancer clinical trials. View Part 1 of this video: http://www.youtube.com/wCollected in Libby's H*O*P*E* May 20, 2010 -
Participating In Cancer Clinical Trials: Part 1 - What You Need To Know
Part 1 of a National Cancer Institute Cancer clinical trials educational video created for people who are considering participation in a trial. The video explains and answers common questions about the types of clinical trials, how they are conducted, and factors to think about when deciding whether or not to participate in a trial. The video also features actual patients who share their reasons and decisions about participating in Cancer clinical trials. View Part 2 of this video: http://www.youtube.com/wCollected in Libby's H*O*P*E* May 20, 2010 -
The National Cancer Institute's NCCCP: "Better Cancer Care, Close to Home."
The National Cancer Institute Community Cancer Centers Program (NCCCP) extends the reach of NCI research into more U.S. states, cities, and towns, including rural areas and inner cities. Learn more about the NCCCP at http://ncccp.cancer.gov. 20 May 10Collected in Libby's H*O*P*E* May 20, 2010 -
What are Clinical Trials?
In this patient education video, Dr. Richard Goldberg explains what clinical trials are, as well as their importance in finding new cancer treatments. 26 April 10Collected in Libby's H*O*P*E* Apr 26, 2010 -
Challenging Cancer Now: Dr. Gottfried Konecny Leads Ovarian Cancer Clinical Trial
Dr. Gottfried Konecny is challenging cancer with a targeted treatment for an aggressive ovarian cancer subtype. Watch the video to learn more. Visit http://www.cancer.ucla.edu/iGive to challenge cancer with a gift that's matched dollar for dollar through the iChallenge. 07 April 10Collected in Libby's H*O*P*E* Apr 7, 2010 -
Volunteers Sought For Avastin Ovarian Cancer Study
Dr. Joan Walker of the OU Cancer Institute is leading a five-year clinical trial that could grow to include 1,800 women across the nation. So far, 13 Oklahomans have enrolled in the study. "The ultimate goal is to find the new ovarian cancer treatment standard of care that can be done nationwide or worldwide and make everyone live longer than 5 years and maybe 10 years,” Walker said. Ovarian cancer usually is detected at an advanced stage and most patients die. That’s why cancer patient Joan Minks of DuraCollected in Libby's H*O*P*E* Mar 3, 2010 -
Woman Fights Ovarian Cancer With ENMD-2076 - 9NEWS.com
Jo Ellen Thorton is living w/ovarian cancer but will not let the disease dominate her life. She is currently enrolled in the ENMD-2076 clinical trial and is experiencing some benefit. 06 Dec. 09Collected in Libby's H*O*P*E* Dec 6, 2009 -
Better clinical trials- Professor Ian Tannock - 2009 NCRI Conference
Professor Tannock talks about how the need for better clinical trials of new cancer treatments. 2009 National Cancer Research Institute Conference 06 Oct. 09Collected in Libby's H*O*P*E* Oct 10, 2009 -
Clinical Challenges in Oncology News from the 2009 ASCO Annual Meeting
Dr. Julie Gralow talks about some of the news about clinical challenges in oncology coming out of the 2009 ASCO Annual Meeting. For more information, visit Cancer.Net (http://www.cancer.net). 01 Jun. 09Collected in Libby's H*O*P*E* Jun 11, 2009
Comments
Libby's H*O*P*E* (tm) Roswell Park Cancer Institute has launched a phase I solid tumor clinical study of a NY-ESO-1 dendritic cell vaccine (in combination with rapamycin) designed to both eradicate cancer cells and prevent disease relapse. (24 Jan 12)
Jan 25, 2012